CV Lattes
ORCID
Abstract
The growing number of bacteria resistant to current antibiotics poses a serious threat to public health services worldwide. At the same time, large pharmaceutical companies have exited this clinical area. A major obstacle in antibiotic discovery is that potent biochemical inhibitors to target essential enzymes often lack in-cell activity. This lack bactericidal activity can be linked to p…